Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roya Eisazadeh

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Imaging|September 30, 2022
<sup>18</sup>F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphomaRoya Eisazadeh, Seyed Ali Mirshahvalad
Seminars in Nuclear Medicine|February 8, 2024
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [<sup>18</sup>F]F-FDG Tracers Part II. [<sup>18</sup>F]F-FLT, [<sup>18</sup>F]F-FET, [<sup>11</sup>C]C-MET and Other Less-Commonly Used RadiotracersRoya Eisazadeh, Malihe Shahbazi-Akbari, Seyed Ali Mirshahvalad, et al.
Seminars in Nuclear Medicine|September 26, 2023
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [<sup>18</sup>F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA RadiotracersSeyed Ali Mirshahvalad, Roya Eisazadeh, Malihe Shahbazi-Akbari, et al.
Seminars in Nuclear Medicine|January 24, 2025
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic ReviewNasibeh Mohseninia, Roya Eisazadeh, Seyed Ali Mirshahvalad, et al.
Nuclear Medicine Communications|September 3, 2024
Automatic detection and segmentation of lesions in 18 F-FDG PET/CT imaging of patients with Hodgkin lymphoma using 3D dense U-NetMohammad Amin Izadi, Nafiseh Alemohammad, Parham Geramifar, et al.
Molecular Imaging and Biology|February 15, 2024
Pre-treatment <sup>68</sup> Ga-PSMA-11 PET/CT Prognostic Value in Predicting Response to <sup>177</sup>Lu-PSMA-I&T Therapy and Patient SurvivalRoya Eisazadeh, Seyed Ali Mirshahvalad, Gregor Schwieghofer-Zwink, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
Impact of [<sup>18</sup>F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint InhibitorsShaghayegh Ranjbar, Seyed Rasoul Zakavi, Roya Eisazadeh, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Imaging|September 30, 2022
<sup>18</sup>F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphomaRoya Eisazadeh, Seyed Ali Mirshahvalad
Seminars in Nuclear Medicine|February 8, 2024
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [<sup>18</sup>F]F-FDG Tracers Part II. [<sup>18</sup>F]F-FLT, [<sup>18</sup>F]F-FET, [<sup>11</sup>C]C-MET and Other Less-Commonly Used RadiotracersRoya Eisazadeh, Malihe Shahbazi-Akbari, Seyed Ali Mirshahvalad, et al.
Seminars in Nuclear Medicine|September 26, 2023
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [<sup>18</sup>F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA RadiotracersSeyed Ali Mirshahvalad, Roya Eisazadeh, Malihe Shahbazi-Akbari, et al.
Seminars in Nuclear Medicine|January 24, 2025
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic ReviewNasibeh Mohseninia, Roya Eisazadeh, Seyed Ali Mirshahvalad, et al.
Nuclear Medicine Communications|September 3, 2024
Automatic detection and segmentation of lesions in 18 F-FDG PET/CT imaging of patients with Hodgkin lymphoma using 3D dense U-NetMohammad Amin Izadi, Nafiseh Alemohammad, Parham Geramifar, et al.
Molecular Imaging and Biology|February 15, 2024
Pre-treatment <sup>68</sup> Ga-PSMA-11 PET/CT Prognostic Value in Predicting Response to <sup>177</sup>Lu-PSMA-I&T Therapy and Patient SurvivalRoya Eisazadeh, Seyed Ali Mirshahvalad, Gregor Schwieghofer-Zwink, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
Impact of [<sup>18</sup>F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint InhibitorsShaghayegh Ranjbar, Seyed Rasoul Zakavi, Roya Eisazadeh, et al.
Pageof 1